Aurobindo Pharma Shares Hit 52-Week High on Getting VAI Classification from USFDA
Aurobindo Pharma shares hit a 52-week high of Rs 1,081.95 on 20 December after the company informed that its wholly owned subsidiary, APL Healthcare Limited,...
Tag : Aurobindo Pharma Ltd
Aurobindo Pharma Shares Gain on Receiving USFDA Approval for Asthma Drug
Shares of Aurobindo Pharma were trading in the green and 2% higher on 30 November after the company’s wholly-owned subsidiary received final approval from the...
Aurobindo Pharma Shares Hit a 52-Week High on Receiving USFDA Approval
Shares of Aurobindo Pharma hit a 52-week high of Rs 1,058 on 22 November after the company’s subsidiary received approval from the USFDA (US Food...
Aurobindo Pharma Trade 1% above as Subsidiary Gets USFDA Nod for Hypogonadism Drug
Shares of Aurobindo Pharma were trading 1% higher on 23 October after the company’s subsidiary got final approval from the USFDA (US Food & Drug...
Aurobindo Pharma Shares Tumble 6% as USFDA Issued One Observation
Aurobindo Pharma shares plummeted 6% and reached an intraday low of Rs 881.10 on 3 October after the USFDA (the US Food and Drug Administration)...
Aurobindo Pharma Shares Trade 1% Below as Arm Gets One Observation from USFDA
Aurobindo Pharma’s shares were trading in the red after the company’s subsidiary, APL Healthcare Limited, on 20 September received a ‘Form 483’ with one observation...
Aurobindo Pharma Plans to Launch HIV Tablets
Aurobindo Pharma on 17 August announced that it will launch a tablet to treat HIV in low-to-middle-income countries. Headquartered in Hyderabad, Aurobindo Pharma manufactures a...
Aurobindo Pharma gets Approval from USFDA for its Icatibant Injection
Eugia Pharma Specialities, a wholly-owned subsidiary of Aurobindo Pharma, on 16 August received approval from the USFDA (United States Food and Drug Administration to manufacture...
Aurobindo Pharma Arm Gets USFDA Approval for Plerixafor Injection
Eugia Pharma, a wholly-owned arm of Aurobindo Pharma Ltd, on July 25 Thursday said it had received final approval from the US Food and Drug...
Aurobindo Pharma Recover Losses After 3 US FDA Observations
Shares of Aurobindo Pharma recovered their initial losses and traded higher at Rs 788.30 at 1:30 pm after the company received three observations from the...